Table 4 Genotype and allele frequencies of BAFF rs2893321 in MG subgroups
From: Associations of BAFF rs2893321 polymorphisms with myasthenia gravis susceptibility
| Â | Myasthenia gravis n (%) | Myasthenia gravis n (%) | ||||||
|---|---|---|---|---|---|---|---|---|
Thymoma | Non-thymoma | χ2 | P | Ocular | General | χ2 | P | |
Genotype | ||||||||
 AA | 30 (42.9%) | 31 (39.2%) | 1.796 | 0.407 | 20 (35.7%) | 41 (44.1%) | 1.883 | .390 |
 GA | 25 (35.7%) | 36 (45.6%) |  |  | 23 (41.1%) | 38 (40.9%) |  |  |
 GG | 15 (21.4%) | 12 (15.2%) |  |  | 13 (23.2%) | 14 (15.1%) |  |  |
Allele | ||||||||
 A | 85 (60.7%) | 98 (62.0%) | 0.054 | 0.817 | 63 (56.2%) | 120 (64.5%) | 2.016 | .156 |
 G | 55 (39.3%) | 60 (38.0%) |  |  | 49 (43.8%) | 66 (35.5%) |  |  |